sponsored
PatientsVille.com Logo

PatientsVille

Metformin and Loratadine

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectMetforminLoratadine
BLOOD GLUCOSE INCREASED4.7% 0.5%
NAUSEA4.1% 3.1%
DRUG INEFFECTIVE2.9% 4.1%
DIARRHOEA3.3% 2.4%
FATIGUE2.4% 3.1%
DYSPNOEA2.1% 2.9%
WEIGHT DECREASED2.7% 1.1%
DIZZINESS2.1% 2.6%
HEADACHE1.8% 2.6%
VOMITING2.5% 1.7%
PAIN1.7% 2.2%
LACTIC ACIDOSIS2% 0%
OFF LABEL USE1.1% 1.9%
MALAISE1.7% 1.8%
ASTHENIA1.6% 1.6%
DECREASED APPETITE1.6% 0.9%
FALL1.3% 1.5%
PNEUMONIA1% 1.5%
RASH1% 1.5%
INSOMNIA0.9% 1.5%
ACUTE KIDNEY INJURY1.5% 0.7%
PAIN IN EXTREMITY1.2% 1.4%
ARTHRALGIA1.1% 1.4%
COUGH0.9% 1.4%
ANXIETY0.8% 1.4%
SOMNOLENCE0.8% 1.4%
DEPRESSION0.7% 1.4%
PRURITUS1% 1.3%
PYREXIA0.8% 1.3%
BACK PAIN0.9% 1.2%
CHEST PAIN0.9% 1.2%
HYPOGLYCAEMIA1.2% 0%
BLOOD GLUCOSE DECREASED1.2% 0%
FEELING ABNORMAL0.9% 1.1%
DRUG DOSE OMISSION1.1% 0.8%
CONDITION AGGRAVATED0.7% 1.1%
INJECTION SITE PAIN1.1% 0.6%
WEIGHT INCREASED1% 1%
DEATH1% 0.9%
HYPERTENSION0.9% 1%
ABDOMINAL PAIN1% 0.9%
CONSTIPATION0.8% 1%
HYPOTENSION1% 0.7%
MYOCARDIAL INFARCTION1% 0.6%
URTICARIA0.4% 1%
RENAL FAILURE ACUTE1% 0%
ABDOMINAL PAIN UPPER0.9% 0.9%
CONFUSIONAL STATE0.8% 0.9%
MUSCLE SPASMS0.7% 0.9%
RENAL FAILURE0.9% 0.7%
DRUG INTERACTION0.9% 0.7%
DEHYDRATION0.9% 0.7%
HYPERSENSITIVITY0.4% 0.9%
ASTHMA0% 0.9%
DIABETES MELLITUS0.9% 0%
ANAEMIA0.8% 0.7%
TREMOR0.7% 0.8%
URINARY TRACT INFECTION0.7% 0.8%
HYPOAESTHESIA0.5% 0.8%
SINUSITIS0% 0.8%
HYPERHIDROSIS0.7% 0.7%
OEDEMA PERIPHERAL0.7% 0.7%
GAIT DISTURBANCE0.7% 0.7%
MYALGIA0.7% 0.7%
PARAESTHESIA0.6% 0.7%
ALOPECIA0.6% 0.7%
CEREBROVASCULAR ACCIDENT0.7% 0.6%
ABDOMINAL DISCOMFORT0.7% 0.6%
BLOOD PRESSURE INCREASED0.6% 0.7%
INCORRECT DOSE ADMINISTERED0.7% 0.6%
NASOPHARYNGITIS0.5% 0.7%
TOXICITY TO VARIOUS AGENTS0.7% 0.5%
PALPITATIONS0% 0.7%
CHRONIC KIDNEY DISEASE0% 0.7%
GASTROOESOPHAGEAL REFLUX DISEASE0% 0.7%
CHEST DISCOMFORT0% 0.7%
GLYCOSYLATED HAEMOGLOBIN INCREASED0.7% 0%
DRUG HYPERSENSITIVITY0.5% 0.6%
MEMORY IMPAIRMENT0.5% 0.6%
PERIPHERAL SWELLING0.5% 0.6%
SYNCOPE0.5% 0.6%
ERYTHEMA0.5% 0.6%
VISION BLURRED0.5% 0.6%
FLUSHING0.6% 0.5%
LOSS OF CONSCIOUSNESS0.5% 0.6%
CARDIAC FAILURE CONGESTIVE0.6% 0%
HEART RATE INCREASED0% 0.6%
DRY MOUTH0% 0.6%
METABOLIC ACIDOSIS0.6% 0%
PANCREATITIS0.6% 0%
DIABETIC KETOACIDOSIS0.6% 0%
COMPLETED SUICIDE0.6% 0%
INJECTION SITE HAEMORRHAGE0.6% 0%
DYSPEPSIA0.5% 0.5%
SEPSIS0.5% 0.5%
ATRIAL FIBRILLATION0.5% 0.5%
MUSCULAR WEAKNESS0.5% 0.5%
GASTROINTESTINAL HAEMORRHAGE0.5% 0.5%
OVERDOSE0.5% 0.5%
HAEMOGLOBIN DECREASED0.4% 0.5%
BRONCHITIS0% 0.5%
SUICIDAL IDEATION0% 0.5%
EXPIRED PRODUCT ADMINISTERED0% 0.5%
PULMONARY EMBOLISM0% 0.5%
BALANCE DISORDER0% 0.5%
AGITATION0% 0.5%
PRODUCT USE ISSUE0% 0.5%
EPISTAXIS0% 0.5%
OROPHARYNGEAL PAIN0% 0.5%
HYPERKALAEMIA0.5% 0%
CHILLS0% 0.5%
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION0% 0.5%
BLADDER CANCER0.5% 0%
HYPERGLYCAEMIA0.5% 0%
DIABETES MELLITUS INADEQUATE CONTROL0.5% 0%
PRODUCT QUALITY ISSUE0.5% 0%
BLOOD CREATININE INCREASED0.5% 0%
ABDOMINAL DISTENSION0.5% 0%
SWELLING FACE0% 0.5%
RENAL IMPAIRMENT0.4% 0%

New treatments are found every day. View current Metformin research studies and Loratadine clinical trials

1